Vascular permeability in a human tumour xenograft: molecular charge dependence.
about
Physiologic upper limit of pore size in the blood-tumor barrier of malignant solid tumorsVEGF pathway targeting agents, vessel normalization and tumor drug uptake: from bench to bedsideProtein comparability assessments and potential applicability of high throughput biophysical methods and data visualization tools to compare physical stability profilesCurrent Approaches for Improving Intratumoral Accumulation and Distribution of Nanomedicines.Polyoxazoline multivalently conjugated with indocyanine green for sensitive in vivo photoacoustic imaging of tumorsInvestigation of the spatiotemporal responses of nanoparticles in tumor tissues with a small-scale mathematical modelA mechanistic tumor penetration model to guide antibody drug conjugate designRapid tumoritropic accumulation of systemically injected plateloid particles and their biodistribution.Increased tumor homing and tissue penetration of the filamentous plant viral nanoparticle Potato virus X.Subtumoral analysis of PRINT nanoparticle distribution reveals targeting variation based on cellular and particle propertiesCharacterization of tumor microvascular structure and permeability: comparison between magnetic resonance imaging and intravital confocal imaging.Frontiers in cancer nanomedicine: directing mass transport through biological barriersOxaliplatin long-circulating liposomes improved therapeutic index of colorectal carcinoma.Strategies for advancing cancer nanomedicine.Tumor-targeted gene delivery using poly(ethylene glycol)-modified gelatin nanoparticles: in vitro and in vivo studies.USNCTAM perspectives on mechanics in medicine.Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology.Delivering nanomedicine to solid tumors.Nanomedical engineering: shaping future nanomedicines.Intratumoral drug delivery with nanoparticulate carriers.Cancer theranostics with gold nanoshells.Overcoming the challenges in the effective delivery of chemotherapies to CNS solid tumors.Fluorescent nanorods and nanospheres for real-time in vivo probing of nanoparticle shape-dependent tumor penetration.Tumour angiogenesis, vascular biology and enhanced drug delivery.Pharmacokinetics of Py-Im polyamides depend on architecture: cyclic versus linear.Delivery of nanomedicines to extracellular and intracellular compartments of a solid tumor.Physical and chemical strategies for therapeutic delivery by using polymeric nanoparticles.Design considerations for nanotherapeutics in oncology.Intratumour heterogeneity in the uptake of macromolecular therapeutic agents in human melanoma xenograftsAntibiological barrier nanovector technology for cancer applications.Peptidomics analysis of human blood specimens for biomarker discovery.Epidermal growth factor receptor-targeted gelatin-based engineered nanocarriers for DNA delivery and transfection in human pancreatic cancer cells.Preparation and characterization of monomethoxy poly(ethylene glycol)-poly(ε-caprolactone) micelles for the solubilization and in vivo delivery of luteolinA nanoparticle formulation that selectively transfects metastatic tumors in miceAntibody tumor penetration: transport opposed by systemic and antigen-mediated clearance.Shape matters: the diffusion rates of TMV rods and CPMV icosahedrons in a spheroid model of extracellular matrix are distinctRecent progress towards development of effective systemic chemotherapy for the treatment of malignant brain tumors.Cationic nanoparticles have superior transvascular flux into solid tumors: insights from a mathematical model.Drug delivery strategies for therapeutic angiogenesis and antiangiogenesis.Superparamagnetic iron oxide nanoparticle 'theranostics' for multimodality tumor imaging, gene delivery, targeted drug and prodrug delivery.
P2860
Q21245468-81ED1819-35E9-42E2-951E-94541C99EA08Q26770678-4676E093-74C1-4CF4-8941-CF576D96319BQ26998787-438A5D38-980F-4670-83D4-29A4BE384152Q27002209-BCC431AC-27AB-4EC2-AC6E-6FA58A2C445EQ27346531-E069A6AF-1AE3-45F7-AF11-87CB75DDCDF9Q28485922-30114B31-5A31-47F0-B8B5-F51FB26FB9D4Q28544636-2DFF669E-6FCF-4DB0-9D68-01C6C6C2556CQ30524254-B77C111C-2315-4F28-9848-BC65820D545AQ30527772-C6677792-03F1-4A50-8C96-2D292BA3FDC4Q30744724-B3D27999-0AE0-44E2-A714-AFFFED8F687AQ33627998-9D5B1E7C-84DA-481B-B76E-23E0CA0266ACQ33746335-E4CE9ABC-E0EF-498C-80AB-BDDC9F882D70Q33845471-1A981869-EFF0-451B-ACAB-0D0F1E43AAC8Q33995719-028DE39A-4B41-4D93-AC0F-07C115314E86Q34063131-1E8EFED2-ACCA-467E-BD81-F2E918A4033BQ34398830-F6967D64-5945-4FB1-A676-D67DD2FAD0FCQ34447986-A7E4CEFE-A05A-4C6E-836B-DF32AF0C125DQ34726981-58E26B4C-6B92-4BFF-B890-7E5DA52EB5D9Q35019550-2C35EE90-9FFB-4404-98FB-B52480D7B596Q35091415-518D4EB4-2FED-4E47-A85C-BEC35BE48763Q35364515-2DFD1D88-84AD-45CC-AEF5-C414EF8BA696Q35602796-8A739F98-D263-44E2-80E1-354B488A18DCQ35677437-DECEF556-A880-411E-91A6-489A1DB67F56Q35931998-B1F365A2-ED72-427C-A369-024C8560AF3DQ35949095-877DAEC9-7795-4E3D-9266-7634CB9726BBQ36043818-1E7DFF95-4A0D-4228-890B-DBB02DF851ECQ36105465-F6A530C3-8BB8-41D9-B969-BD2F60505259Q36236848-1D895AAD-2DD9-49D0-859A-BDDB9DFDB1EEQ36648697-E9F57A6A-126A-4BC0-B3D2-B5E841AE3139Q36903797-3A504A0A-B19B-41D2-A379-CA5F130679CDQ36950443-ACC69C7F-07C9-4017-980C-C74D06C38411Q37065810-4244527C-91C1-4DFB-BD57-35E982570FB8Q37109221-9C5CEC21-ADEC-4A18-ABCB-6FD4C2566862Q37157373-FEBB507D-21A1-4681-BB49-7A30D322EBE0Q37187003-5C94417D-736F-40FF-BED6-640A4EAD52B1Q37298480-4320D4AA-4EAB-4A08-904D-11D8C519689CQ37346039-4EA29170-BADD-4F7C-B9CC-749653754317Q37457535-1BE2E7ED-19C1-4C1F-BD1C-DDE182B86946Q37845396-DE497970-4DAD-4AB0-BACA-EEA4C7C9A125Q37960075-2EC9FAE7-C091-4302-8F8E-22148D6BABCF
P2860
Vascular permeability in a human tumour xenograft: molecular charge dependence.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Vascular permeability in a human tumour xenograft: molecular charge dependence.
@ast
Vascular permeability in a human tumour xenograft: molecular charge dependence.
@en
type
label
Vascular permeability in a human tumour xenograft: molecular charge dependence.
@ast
Vascular permeability in a human tumour xenograft: molecular charge dependence.
@en
prefLabel
Vascular permeability in a human tumour xenograft: molecular charge dependence.
@ast
Vascular permeability in a human tumour xenograft: molecular charge dependence.
@en
P2093
P2860
P356
P1476
Vascular permeability in a human tumour xenograft: molecular charge dependence.
@en
P2093
V P Torchilin
V S Trubetskoy
P2860
P2888
P304
P356
10.1054/BJOC.1999.1171
P407
P577
2000-05-01T00:00:00Z
P5875
P6179
1036653835